Laila Silamiķele

发表

Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes

R. Petrovska, J. Klovins, M. Ustinova, 2020, bioRxiv.

First Report on the Latvian SARS-CoV-2 Isolate Genetic Diversity

J. Klovins, B. Vilne, J. Storoženko, 2020, Frontiers in Medicine.

Exercise-Induced Extracellular Vesicles Delay the Progression of Prostate Cancer

A. Linē, P. Zayakin, L. Sadovska, 2022, Frontiers in Molecular Biosciences.

Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response

J. Klovins, I. Konrāde, V. Pīrāgs, 2020, PloS one.

Novel susceptibility loci identified in a genome-wide association study of type 2 diabetes complications in population of Latvia

L. Zaharenko, J. Klovins, I. Konrāde, 2021, BMC Medical Genomics.

Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients

L. Zaharenko, J. Klovins, I. Konrāde, 2020, PloS one.

Spatial variation of the gut microbiome in response to long-term metformin treatment in high-fat diet-induced type 2 diabetes mouse model of both sexes

D. Fridmanis, I. Silamiķelis, I. Kalniņa, 2023, Gut microbes.

Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance

I. Kalniņa, L. Ansone, L. Birzniece, 2023, Frontiers in endocrinology.